Who owns Pluristem Therapeutics Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Pluristem Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Pluristem Therapeutics stock

Who bought or sold Pluristem Therapeutics Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
ARK Investment Management 1.4M $5.4M -62% Jun 2021
Susquehanna International 487k $1.9M -37% Jun 2021
Renaissance Technologies 406k $1.6M 23% Jun 2021
Nia Impact Advisors 385k $1.5M 7% Jun 2021
Citadel Advisors 320k $1.3M 25% Jun 2021
SG3 Management 222k $878k 1462% Jun 2021
CCM Partners 220k $871k 0% Jun 2021
Bridgeway Capital Management 195k $772k 491% Jun 2021
Meitav Dash Investments 168k $664k 0% Jun 2021
GSA Capital Partners 160k $633k 100% Jun 2021
Caption Management 153k $605k 100% Jun 2021

Setup an alert

Want to be notified whenever an investor makes a significant change to their holdings of Pluristem Therapeutics?

Walleye Trading Advisors 123k $488k 100% Jun 2021
Nikko Asset Management Americas 121k $473k 0% Jun 2021
Sumitomo Mitsui Trust Holdings 121k $478k 0% Jun 2021
HAP Trading 102k $87k 821% Jun 2021
Morgan Stanley 77k $302k 100% Jun 2021
Jpmorgan Chase & Co 75k $360k 1038% Mar 2021
Jane Street 61k $243k -93% Jun 2021
Jordan Park Group 60k $237k 100% Jun 2021
Group One Trading 55k $219k -3% Jun 2021
Walleye Trading 50k $197k 90% Jun 2021
D. E. Shaw & Co 44k $174k 100% Jun 2021
Focused Wealth Management 41k $162k 0% Jun 2021
State Street Corporation 39k $156k 1% Jun 2021
Jump Financial 34k $134k 57% Jun 2021
PDT Partners 34k $133k 100% Jun 2021
Zurcher Kantonalbank 31k $124k 5% Jun 2021
Cutler 30k $117k 60% Jun 2021
Simplex Trading 30k $116k 297% Jun 2021
Pathstone Family Office 17k $68k 100% Jun 2021
Algert Coldiron Investors 16k $62k -42% Jun 2021
HighTower Advisors 15k $54k 22% Jun 2021
Susquehanna International Group 14k $55k 100% Jun 2021
Wolverine Trading 14k $56k -54% Jun 2021
Susquehanna Fundamental Investments 13k $53k 100% Jun 2021
Archford Capital Strategies 13k $52k 0% Jun 2021
Geode Capital Management 13k $50k 0% Jun 2021
Raymond James & Associates 10k $41k 0% Jun 2021
Cowen And Company 10k $40k 100% Jun 2021
UBS Group 9.8k $0 -51% Jun 2021
Wells Fargo & Company 7.0k $28k 16% Jun 2021
BlackRock 6.7k $26k 100% Jun 2021
Bank of America Corporation 5.1k $20k 286% Jun 2021
Advisor Group Holdings 4.6k $19k 31% Jun 2021
Banque Cantonale Vaudoise 3.2k $13k 0% Jun 2021
Harbour Investments 2.4k $10k 3% Jun 2021
Proequities 1.8k $7.0k 0% Jun 2021
Firestone Capital Management 1.6k $6.0k 0% Jun 2021
Endurance Wealth Management 1.5k $5.0k 0% Jun 2021
Royal Bank of Canada 1.0k $4.0k 0% Jun 2021
Baldwin Brothers 740.00 $3.0k 0% Jun 2021
Us Bancorp 500.00 $2.0k 100% Jun 2021
NEXT Financial 500.00 $2.0k 0% Jun 2021
BDO Wealth Advisors 400.00 $2.0k 0% Jun 2021
Winch Advisory Services 209.00 $1.0k 0% Jun 2021
Riggs Asset Managment 155.00 $999.998000 0% Jun 2021
TFC Financial Management 149.00 $999.998600 0% Jun 2021
Citigroup 79.00 $0 -24% Mar 2021
IFP Advisors 0 $0 -100% Jun 2021

Who sold out of Pluristem Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Two Sigma Investments Mar 2021 214k $1.0M
Two Sigma Advisers Mar 2021 199k $947k
Etf Managers Mar 2021 75k $340k
Sabby Management Mar 2021 51k $242k
Millennium Management Mar 2021 49k $231k
CalPERS Mar 2021 48k $227k
Hrt Financial Mar 2021 15k $72k
Van Eck Associates Corp. Mar 2021 7.8k $37k
Sowell Financial Services Mar 2021 3.8k $15k
Tower Research Capital Mar 2021 3.6k $33k
International Assets Investment Management Mar 2021 800.00 $6.0k
Steward Partners Investment Advisory Mar 2021 504.00 $2.4k
Certified Advisory Corp Mar 2021 500.00 $2.0k
Holloway Wealth Management Mar 2021 125.00 $1.0k
Bank Of Montreal Mar 2021 120.00 $999.996000
Wealthcare Advisory Partners Mar 2021 100.00 $0